AGMB insider trading
AgomAb Therapeutics NV
In the past 36 days, 3 insiders bought $311K of AgomAb Therapeutics NV stock in 4 open-market purchases. The largest purchase was $94K by Tim Jasper Knotnerus (Chief Executive Officer) on Oct 5, 2026.
Cluster buying: 3 different insiders bought $311K between Oct 5, 2026 and Oct 8, 2026.
Insider purchases
| Insider | Value | Holdings | Signal | Traded / filed |
|---|---|---|---|---|
David R Epstein Director |
$44K 5,000 sh @ $8.90 |
+50.0% | Medium
|
Oct 8, 2026 Filed Oct 9, 2026 |
Pierre Thadee Victor Kemula Chief Financial Officer |
$86K 10,000 sh @ $8.59 |
New position | High
|
Oct 6, 2026 Filed Oct 7, 2026 |
Tim Jasper Knotnerus Chief Executive Officer |
$94K 11,000 sh @ $8.58 |
+101.6% | High
|
Oct 5, 2026 Filed Oct 7, 2026 |
David R Epstein Director |
$86K 10,000 sh @ $8.63 |
New position | High
|
Oct 5, 2026 Filed Oct 7, 2026 |
Insider sales
No open-market sales by insiders in this period.